RaySearch Laboratories AB (publ) announces the release of RayStation® 9B*. The latest version of its innovative treatment planning system offers several enhancements, including support for chemotherapy planning and next-level machine learning capabilities, as well as further integration with its oncology information system RayCare®*.
Support for chemotherapy is among the significant enhancements of the latest version of the treatment planning system RayStation. Other features of RayStation 9B, the second major update this year, involves deep learning segmentation using multi-modality images and machine learning capabilities enabling planning for multi-beam set plans. These enhancements enable powerful automation for even more treatment set-ups.
RayStation 9B introduces support for medical oncology with a new module for management and prescription of chemotherapy treatments. This includes tools to build a library of medical oncology regimen templates, to be used and adapted for individual patients, cycle-by-cycle approvals, and report generation for use during treatment administration. Additional tools include those for registering, activating and inactivating active substances to be used.
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
RayStation 9B includes real-time tracking and motion management support for TomoHelical plans (Synchrony®), as well as VSim plan approval and the ROI protect option for VMAT. Enhancements for particle therapy include support for Siemens Dual Energy CT in dose calculation, seated treatments, and full support for Hitachi proton treatment machines and Toshiba carbon ion systems. Also, the speed in Multi-Criteria Optimization for protons is significantly improved by the use of cached spot doses.
Improved support for large image datasets and further integration with RayCare, such as the possibility to run RayStation scripts from tasks in the oncology information system, is also included in the new release.
Johan Löf, founder and CEO of RaySearch, says: “With each new version of our RayStation software, we are advancing patient treatment planning with innovation and the latest in digital technology. Adding support for chemotherapy is the first application of RayStation outside of radiation therapy and it signifies important broadening of our support for comprehensive cancer care.”
About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare®*, the next-generation oncology information system, worldwide. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.
